Atlas Trials

Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis

Clinical trial NCT07728721 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07728721
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis (IPF)
Start date
2026-08-25
Primary completion
2028-04-10
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.